Non-invasive high frequency oscillatory ventilation for primary respiratory support in extremely preterm infants: multicentre randomised controlled trial.

Name: Αlpha¹ Rigor Record — Non-invasive high frequency oscillatory ventilation for primary respiratory support in extremely preterm infants: multicentre randomised controlled trial.
Item: Non-invasive high frequency oscillatory ventilation for primary respiratory support in extremely preterm infants: multicentre randomised controlled trial.
Rating: 100
Author: Αlpha¹

Li Y, Zhu X, Li LJ, Chen L, Yang Q, Xu L, Liang W, Lin X, Li C, Xue J, Liu L, Pan X, Ju R, Peng X, Tang W, Shi Y, NHFOV study group

Paper source

Read full text (PMC)

Embed this Rigor badge

Αlpha¹ Rigor Review — 5★ (Exemplary), 0 critical, 2 high issues for “Non-invasive high frequency oscillatory ventilation for primary respiratory support in extremely preterm infants: multicentre randomised controlled trial.”

Links back to this Rigor Record.

Αlpha¹ Editorial

This rigor review was examined and confirmed by Αlpha¹ Editorial · August 15, 2026

Αlpha¹ Rigor Review

Rigor Reviewed

5 / 5

Exemplary — no material problems found

Interventional Study

Critical

High-priority

How this rating was calculated▸

Started at 5★ — no deductions. Nothing the checks ran surfaced a material problem.

Model-reported confidence: highReviewer agreement: highEngine: 7.39.0Source: full text

Problems surfaced1 type

Overstated conclusions1

Conclusions that reach past what the paper's own results support — including a significance claim that no longer holds when the statistic is recomputed, and efficacy resting on an unvalidated surrogate endpoint.

Conclusions only partially backed by the presented evidenceAssessed

This Αlpha¹ Rigor Review uses AI Rigor Reviewers trained on a curated corpus of high-fidelity and retracted papers, with expert supervision and curation. It can still make mistakes; verify each finding against the source before relying on it.

This is a well-conducted and well-reported multicentre RCT comparing NHFOV with NCPAP in extremely preterm infants. The paper demonstrates strong methodological rigor across all eight dimensions, with minor reporting gaps in outlier handling and statistical assumption verification.

Both reviewers classified the study as interventional, which is adopted. The evaluation covers all eight dimensions; no dimensions were excluded as not applicable. The reviewers converged closely, with minor disagreements on outlier handling and demographics reporting, which were resolved by weighing the evidence.

7 major claims checked against the paper's own evidence: 1 only partially supported (evidence backs part of the claim; gaps or caveats remain); the rest adequately supported.

Efficacy claim is anchored to an adequate endpoint and a meaningful effect.

Recomputed 2 tests: 2 consistent, 0 inconsistent; 2 via agent-written checks.

Reporting

Eight Dimensions8 pass

The paper cites prior work on NCPAP failure rates and NHFOV's physiological advantages, and notes inconsistent findings from previous RCTs. The hypothesis follows logically from the cited evidence. Limitations of prior research (e.g., inconsistent findings, underpowered studies) are acknowledged and addressed by the trial's design.

Sub-criteria

prior work citedADEQUATE

premise rationaleADEQUATE

limitations addressedADEQUATE

Per reviewer (2) — the votes behind the verdict

PASSReviewer 1· 90% conf

The introduction establishes a clear rationale for comparing NHFOV with NCPAP, citing prior research and identifying the gap in evidence.

Evidence

direct quote[Introduction, paragraph 1]

“However, cumulative evidence has suggested that up to 40% of extremely preterm infants are prone to a high risk of NCPAP failure because of chest wall collapse and poor diaphragmatic strength.”